Company overview
Basic information
Company name
Bprekyba, MB
Company code
306879031
Registered address
Kaunas, Sukilėlių pr. 69-7, LT-49325
Registration date
2024-06-25
Company age: 2 y. 3 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
Bprekyba, MB
Company code: 306879031
Address: Kaunas, Sukilėlių pr. 69-7, LT-49325
Download a detailed company report
Make confident decisions with all the information about Bprekyba, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Bprekyba, MB (company code 306879031) is a private small partnership registered in 2024 and currently operational. It belongs to the sector of national private non-financial companies and is owned under private ownership, where Lithuanian natural and legal persons hold more than 50% of the authorised capital and there is no foreign investor capital. The company is governed by a CEO only and is classified as a micro company. Its registered address is in Kaunas, Kauno m. sav., Kauno apskr., at Sukileliu pr. 69-7.
The company’s main activity is retail sale of pharmaceutical products, under EVRK code G.47.73.00. Financially, Bprekyba generated €27.4K in revenue in 2024 over a 189-day period and reported net profit of €4.1K. In 2025, revenue declined to €18.3K, and the company recorded a net loss of €3.6K, with a profit margin of -19.6%. The latest financial year therefore shows weaker performance compared with 2024. Staff data is reported so far in 2026, but no average employee or wage figures are provided.
The company’s main activity is retail sale of pharmaceutical products, under EVRK code G.47.73.00. Financially, Bprekyba generated €27.4K in revenue in 2024 over a 189-day period and reported net profit of €4.1K. In 2025, revenue declined to €18.3K, and the company recorded a net loss of €3.6K, with a profit margin of -19.6%. The latest financial year therefore shows weaker performance compared with 2024. Staff data is reported so far in 2026, but no average employee or wage figures are provided.